108 related articles for article (PubMed ID: 8062900)
1. Prolonged bone marrow aplasia of refractory prolymphocytoid variant of B-cell chronic lymphocytic leukemia related to fludarabine treatment.
Zinzani PL; Tabanelli M; Bendandi M; Tura S
Eur J Haematol; 1994 Jul; 53(1):56-8. PubMed ID: 8062900
[No Abstract] [Full Text] [Related]
2. Sustained response of refractory prolymphocytic leukemia to fludarabine.
Sporn JR
Acta Haematol; 1991; 85(4):209-11. PubMed ID: 1853684
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemia.
Kantarjian HM; Childs C; O'Brien S; Huh Y; Beran M; Schachner J; Koller C; Keating MJ
Am J Med; 1991 Feb; 90(2):223-8. PubMed ID: 1996592
[TBL] [Abstract][Full Text] [Related]
4. "Prolymphocytoid" transformation of chronic lymphocytic leukemia.
Singh VP; Sundar S; Kumar K; Shukla J; Dube B
J Assoc Physicians India; 1993 May; 41(5):312. PubMed ID: 8300471
[No Abstract] [Full Text] [Related]
5. Probable autoimmune neutropenia induced by fludarabine treatment for chronic lymphocytic leukaemia.
Stern SC; Shah S; Costello C
Br J Haematol; 1999 Sep; 106(3):836-7. PubMed ID: 10469479
[No Abstract] [Full Text] [Related]
6. Involvement of central nervous system in prolymphocytoid transformation of chronic lymphocytic leukemia.
Kuwabara H; Kanamori H; Takasaki H; Takabayashi M; Yamaji S; Tomita N; Fujimaki K; Fujisawa S; Ishigatsubo Y
Leuk Lymphoma; 2003 Jul; 44(7):1235-7. PubMed ID: 12916878
[TBL] [Abstract][Full Text] [Related]
7. Richter syndrome and fludarabine: a controversial relationship.
Rossi D
Leuk Lymphoma; 2013 Feb; 54(2):213-4. PubMed ID: 22897730
[No Abstract] [Full Text] [Related]
8. Effectiveness of fludarabine in end-stage prolymphocytic leukemia.
Doorduijn JK; Michiels JJ
Leukemia; 1994 Aug; 8(8):1439. PubMed ID: 8057685
[No Abstract] [Full Text] [Related]
9. Treatment of refractory T-cell chronic lymphocytic leukemia with purine nucleoside analogues.
Witzig TE; Weitz JJ; Lundberg JH; Tefferi A
Leuk Lymphoma; 1994 Jun; 14(1-2):137-9. PubMed ID: 7920220
[TBL] [Abstract][Full Text] [Related]
10. Treatment of red cell aplasia in CLL with fludarabine.
Ribeiro I; Tsatalas C; Catovsky D
Leukemia; 1999 Nov; 13(11):1897. PubMed ID: 10557069
[No Abstract] [Full Text] [Related]
11. Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia.
Montillo M; Tedeschi A; O'Brien S; Di Raimondo F; Lerner S; Ferrajoli A; Morra E; Keating MJ
Cancer; 2003 Jan; 97(1):114-20. PubMed ID: 12491512
[TBL] [Abstract][Full Text] [Related]
12. The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011).
Solh M; Rai KR; Peterson BL; Kolitz JE; Appelbaum FR; Tallman MS; Belch A; Larson RA; Morrison VA
Leuk Lymphoma; 2013 Feb; 54(2):252-4. PubMed ID: 22897733
[TBL] [Abstract][Full Text] [Related]
13. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
Rai KR; Peterson BL; Appelbaum FR; Kolitz J; Elias L; Shepherd L; Hines J; Threatte GA; Larson RA; Cheson BD; Schiffer CA
N Engl J Med; 2000 Dec; 343(24):1750-7. PubMed ID: 11114313
[TBL] [Abstract][Full Text] [Related]
14. Acute tumor lysis syndrome complicating fludarabine treatment of prolymphocytic leukemia.
Cannon LM; Spilove L; Rhodes R; Garfinkel H; Pezzimenti J
Conn Med; 1993 Oct; 57(10):651-4. PubMed ID: 8275684
[TBL] [Abstract][Full Text] [Related]
15. [Successful treatment for advanced and refractory chronic lymphocytic leukemia with fludarabine phosphate].
Takeuchi M; Tada A; Soda R; Takahashi K
Rinsho Ketsueki; 1997 Sep; 38(9):792-4. PubMed ID: 9364873
[TBL] [Abstract][Full Text] [Related]
16. Fludarabine and prednisone in pretreated and refractory B-chronic lymphocytic leukemia (B-CLL) in advanced stages.
De Rossi G; Mauro FR; Caruso R; Monarca B; Mandelli F
Haematologica; 1993; 78(3):167-71. PubMed ID: 8375746
[TBL] [Abstract][Full Text] [Related]
17. Pure red-cell aplasia with fludarabine for chronic lymphocytic leukaemia.
Leporrier M; Reman O; Troussard X
Lancet; 1993 Aug; 342(8870):555. PubMed ID: 8102691
[No Abstract] [Full Text] [Related]
18. Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.
Rai KR; Freter CE; Mercier RJ; Cooper MR; Mitchell BS; Stadtmauer EA; Santábarbara P; Wacker B; Brettman L
J Clin Oncol; 2002 Sep; 20(18):3891-7. PubMed ID: 12228210
[TBL] [Abstract][Full Text] [Related]
19. Fludarabine for prolymphocytic leukaemia and risk of interstitial pneumonitis.
Cervantes F; Salgado C; Montserrat E; Rozman C
Lancet; 1990 Nov; 336(8723):1130. PubMed ID: 1700245
[No Abstract] [Full Text] [Related]
20. Refractory pure red-cell aplasia associated with B chronic lymphocytic leukemia successfully treated by fludarabine.
Sandra S; Real E; Pastor E; Grau E
Haematologica; 1999 Dec; 84(12):1154-5. PubMed ID: 10586218
[No Abstract] [Full Text] [Related]
[Next] [New Search]